- General population
- Infants (<1 year)
- Adolescents (12-17 years)
- Children (1-11 years)
- Hospital
- SARS-CoV-2
- Post COVID-19 condition
Population: Adolescents (12-17 years)
- Adults (18-64 years)
- Elderly (≥65 years)
- Adolescents (12-17 years)
- Children (1-11 years)
- Community
- SARS-CoV-2
- Post COVID-19 condition
- Adults (18-64 years)
- Elderly (≥65 years)
- Adolescents (12-17 years)
- Hospital
- SARS-CoV-2
- Post COVID-19 condition
- Adults (18-64 years)
- Elderly (≥65 years)
- Adolescents (12-17 years)
- Children (1-11 years)
- Primary care
- SARS-CoV-2
- Post COVID-19 condition
- Adults (18-64 years)
- Elderly (≥65 years)
- Adolescents (12-17 years)
- Outpatient clinic
- SARS-CoV-2
- Post COVID-19 condition
- Adults (18-64 years)
- Adolescents (12-17 years)
- Children (1-11 years)
- Community
- SARS-CoV-2
- Acute COVID-19
- Nasopharyngeal swab
- Non pharmacological intervention
- Infants (<1 year)
- Adolescents (12-17 years)
- Children (1-11 years)
- Hospital
- SARS-CoV-2
- Acute COVID-19
- Pharmacological intervention
- Antivirals
- Remdesivir
- Adults (18-64 years)
- Elderly (≥65 years)
- Fragile population
- Adolescents (12-17 years)
- Emergency department
- SARS-CoV-2
- Acute COVID-19
- Pharmacological intervention
- Monoclonal antibodies
- Sotrovimab
- Adults (18-64 years)
- Elderly (≥65 years)
- Fragile population
- Adolescents (12-17 years)
- Hospital
- Outpatient clinic
- SARS-CoV-2
- Acute COVID-19
- Pharmacological intervention
- Monoclonal antibodies
- Sotrovimab
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Adolescents (12-17 years)
- Community
- Primary care
- SARS-CoV-2
- Acute COVID-19
- Pharmacological intervention
- Antivirals
- Monoclonal antibodies
- Nirmatrelvir/Ritonavir
- Sotrovimab
- Molnupiravir
- Adults (18-64 years)
- Elderly (≥65 years)
- Infants (<1 year)
- Adolescents (12-17 years)
- Children (1-11 years)
- Hospital
- SARS-CoV-2
- Influenza virus
- Influenza A(H5N1) virus
- Influenza
- Avian Influenza
- Pharmacological intervention
- Antivirals
- Corticosteroid
- Baloxavir
- Oseltamivir
- Infants (<1 year)
- Adolescents (12-17 years)
- Children (1-11 years)
- Hospital
- Outpatient clinic
- Community
- Primary care
- Non-hospital health centre
- Emergency department
- SARS-CoV-2
- Post COVID-19 condition
- Acute COVID-19